

Publisher: Bentham Science Publishers
E-ISSN: 2212-3903|5|1|67-74
ISSN: 1574-8855
Source: Current Drug Therapy, Vol.5, Iss.1, 2010-02, pp. : 67-74
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Extrapulmonary tuberculosis refers to disease other than the lungs. The recent pandemic of Human Immunodeficiency Virus (HIV) and Acquired Immunodeficiency Syndrome (AIDS) has changed the epidemiology of tuberculosis and has once again brought extrapulmonary tuberculosis into the limelight. Over the last two decades the incidence of extrapulmonary tuberculosis has increased at a faster rate than that of pulmonary tuberculosis. The clinical manifestations of extrapulmonary tuberculosis are mostly nonspecific and insidious, resulting in delay of the diagnosis. Extrapulmonary tuberculosis is usually paucibacillary and any treatment regimen that is effective for treating pulmonary tuberculosis is also likely to be effective for the treatment of extrapulmonary tuberculosis. Short-course therapy is mostly suitable for most patients with extrapulmonary tuberculosis, but patients having HIV infection require longer treatment. Extrapulmonary tuberculosis is a persistent problem around the world and is becoming more prevalent as the number of AIDS patients is increased. A high index of suspicion is require for diagnosis and treatment of extrapulmonary tuberculosis, since extrapulmonary tuberculosis can involve any organ system. In this review an attempt has been made to provide a critical overview of the management and control of more commonly encountered forms of extrapulmonary tuberculosis.
Related content




Acne and its Management Beyond the Age of 35 Years
By Ronnie Marks
American Journal of Clinical Dermatology, Vol. 5, Iss. 6, 2004-01 ,pp. :


Anakinra: A Review of its Use in the Management of Rheumatoid Arthritis
By Waugh John Perry Caroline M.
BioDrugs, Vol. 19, Iss. 3, 2005-01 ,pp. :


Daclizumab: A Review of its Use in the Management of Organ Transplantation
By Carswell C.I. Plosker G.L. Wagstaff A.J.
BioDrugs, Vol. 15, Iss. 11, 2001-01 ,pp. :